Venlafaxine

Tracking # 20-633327

$14.00

4.6 (5 ratings)

Educator NURSECE4LESS.COM

CE Broker Reporting Reported automatically

Method Home Study

Course overview

Venlafaxine is an antidepressant medication with potent inhibitors of neuronal serotonin and norepinephrine reuptake and weak dopamine reuptake inhibitors. Antidepressant medications such as venlafaxine are considered first-line treatments for patients with moderate to severe major depressive disorder. Serotonin and norepinephrine reuptake inhibitors have been approved in the United States by the Food and Drug Administration for the treatment of major depressive disorders in adults and is now commonly used in many other countries. Venlafaxine is marketed in both immediate and extended release formulas, and has been reported to be associated with better response rates when compared to other antidepressants with higher discontinuation outcomes. No Test Required!

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Midwife

2.5h Practice-Focused Continuing Education

2.5h Pharmacotherapeutics continuing education in the area of certification

Certified Nurse Practitioner

2.5h Practice-Focused Continuing Education

2.5h Pharmacotherapeutics continuing education in the area of certification

Certified Registered Nurse Anesthetist

2.5h Practice-Focused Continuing Education

2.5h Pharmacotherapeutics continuing education in the area of certification

Clinical Nurse Specialist

2.5h Pharmacotherapeutics continuing education in the area of certification

2.5h Practice-Focused Continuing Education

Licensed Practical Nurse

2.5h Practice-Focused Continuing Education

Licensed Psychiatric Technician Nurse

2.5h Practice-Focused Continuing Education

Registered Nurse

2.5h Practice-Focused Continuing Education

Registered Nurse Practitioner

2.5h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Certified Nurse Midwife

2.5h Relevant to Clinical Nurse Midwife Specialty

2.5h Pharmacology Component

Clinical Nurse Specialist

2.5h Relevant to Clinical Nurse Specialty

2.5h Pharmacology Component

Licensed Practical Nurse

2.5h Licensed Practical Nurse - Continuing Education

Nurse Practitioner

2.5h Pharmacology Component

2.5h Relevant to Nurse Practitioner Specialty

Registered Nurse

2.5h Registered Nurse District of Columbia - Continuing Education

Registered Nurse Anesthetist

2.5h Pharmacology Component

2.5h Relevant to Registered Nurse Anesthetist Specialty

Florida Board of Nursing

Advanced Practice Registered Nurse

2.5h General

Clinical Nurse Specialist

2.5h General

Licensed Practical Nurse

2.5h General

Registered Nurse

2.5h General

Georgia Board of Nursing

Licensed Practical Nurse

2.5h General

Registered Professional Nurse

2.5h General

New Mexico Board of Nursing

Certified Nurse Practitioner

2.5h Continuing education related to pharmacology

2.5h Continuing education relevant to nursing practice

Certified Registered Nurse Anesthetist

2.5h Continuing education related to pharmacology

2.5h Continuing education relevant to nursing practice

Clinical Nurse Specialist

2.5h Continuing education related to pharmacology

2.5h Continuing education relevant to nursing practice

Licensed Practical Nurse

2.5h Continuing education relevant to the licensed practical nurse

Registered Nurse

2.5h Continuing education relevant to nursing practice

South Carolina Board of Nursing

Advanced Practice Registered Nurse

2.5h Pharmacotherapeutics

2.5h General

Licensed Practical Nurse

2.5h Pharmacotherapeutics

2.5h General

Registered Nurse

2.5h Pharmacotherapeutics

2.5h General

West Virginia Board of Registered Nurses

Advanced Practice Registered Nurse

2.5h Professional nursing practice and special health care problems

Registered Nurse

2.5h Professional nursing practice and special health care problems

Disclosure statements

Policy Statement

This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and the continuing nursing education requirements of the American Nurses Credentialing Center's Commission on Accreditation for registered nurses.

Continuing Education Credit Designation

This educational activity is credited for 2.5 hours at completion of the activity. Pharmacology content is 2.5 hours.

Statement of Learning Need

Health clinicians need to know that venlafaxine is an antidepressant medication and is generally considered a first-line treatment for patients with moderate to severe major depressive disorder, and is marketed in both immediate and extended release formulas. Venlafaxine is also considered a first-choice pharmacological therapy for generalized anxiety disorder, which has been established during clinical trials and in subsequent research.

Course Purpose

To inform health clinicians of the indications, uses, contraindications and potential side effects of venlafaxine.

Target Audience

Advanced Practice Registered Nurses, Registered Nurses, and other Interdisciplinary Health Team Members.

Disclosures

Dana Bartlett, RN, BSN, MSN, MA, CSPI, William Cook, PhD, Douglas Lawrence, MA, Kellie Wilson, PharmD, Susan DePasquale, MSN, FPMHNP-BC – all have no disclosures. There is no commercial support.

Learner Feedback